We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CT AI Algorithm Categorizes Lung Nodule Cancer Risk

By MedImaging International staff writers
Posted on 20 May 2020
Print article
Image: Indeterminate pulmonary nodules on a lung CT (Photo courtesy of Optellum)
Image: Indeterminate pulmonary nodules on a lung CT (Photo courtesy of Optellum)
A new study indicates that an artificial intelligence (AI) strategy can correctly assess and categorize suspicious indeterminate pulmonary nodules (IPNs).

Developed at Vanderbilt University (Nashville, TN, USA), Optellum (Oxford, United Kingdom), and other institutions, the lung cancer prediction convolutional neural network (LCP-CNN) model was first trained using computerized tomography (CT) images of IPNs from the U.S. National Lung Screening Trial (NLST), internally validated, and externally tested on cohorts from two academic institutions. The researchers then compared the LCP-CNN to traditional risk prediction models on a very large dataset of 15,693 nodules.

The results showed that the AI risk model was associated with an improved accuracy in the predicted disease risk calculation at each threshold of therapy management, as well as in the external validation cohorts. When compared to conventional risk models currently used, the LCP-CNN algorithm reclassified the IPNs into low-risk or high-risk categories in over a third of cancers and benign nodules. The study was published on April 24, 2020, in the American Journal of Respiratory and Critical Care Medicine.

“The management IPNs remains challenging, and strategies to decrease the rate of unnecessary invasive procedures and to optimize surveillance regimens are needed,” concluded lead author Professor Pierre Massion, MD, of Vanderbilt University, and colleagues. “This study demonstrates that this deep learning algorithm can correctly reclassify IPNs into low or high-risk categories, potentially reducing the number of unnecessary invasive procedures and delays in diagnosis.”

Deep learning is part of a broader family of AI machine learning methods that use data representations, as opposed to task specific algorithms. It involves CNN algorithms that execute a cascade of many layers of nonlinear processing units in order to enable feature extraction, conversion, and transformation. Each successive layer uses the output from the previous layer as input to form a hierarchical representation.

Related Links:
Vanderbilt University
Optellum


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
Ultrasound System
P25 Elite
Compact C-Arm with FPD
Arcovis DRF-C R21

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.